| Rachel Lynne Davis, AGACNP-BC | |
|
190 E Bannock St, Boise, ID 83712-6241 | |
| (208) 381-2222 | |
| Not Available |
| Full Name | Rachel Lynne Davis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 190 E Bannock St, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174156962 | NPI | - | NPPES |
| 63884 | Other | ID | APRN-CNP LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 63884 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumour.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma.
› Verified 8 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumour.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Lynne Davis, AGACNP-BC 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 | Rachel Lynne Davis, AGACNP-BC 190 E Bannock St, Boise, ID 83712-6241 Ph: (208) 381-2222 |
News Archive
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Chemotherapy is frequently given to women with breast cancer after surgery to remove the main bulk of the tumour.
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma.
› Verified 8 days ago
Nora M Suarez, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Dr. Nancy Jane L'heureux, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 | |
Jennifer Woodburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-5015 | |
Carl Ciplinski, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10583 W Lake Hazel Rd, Boise, ID 83709 Phone: 208-302-5950 | |
Kathryn Laura Cnossen, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8000 S Federal Way, Boise, ID 83716 Phone: 208-368-2109 | |
Mrs. Chelsea Rose Wallace, RN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9976 W Emerald St, Boise, ID 83704 Phone: 208-229-3742 | |
Natasha Michele King-anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 707 N Armstrong Pl, Boise, ID 83704 Phone: 208-375-5211 |